Adderley, H., Ackermann, C. J., & Califano, R. (2019). Erlotinib plus bevacizumab for EGFR-mutant advanced non-squamous non-small-cell lung cancer patients: Ready for first-line? Ann Transl Med.
Chicago Style CitationAdderley, Helen, Christoph Jakob Ackermann, i Raffaele Califano. "Erlotinib Plus Bevacizumab for EGFR-mutant Advanced Non-squamous Non-small-cell Lung Cancer Patients: Ready for First-line?" Ann Transl Med 2019.
Cita MLAAdderley, Helen, Christoph Jakob Ackermann, i Raffaele Califano. "Erlotinib Plus Bevacizumab for EGFR-mutant Advanced Non-squamous Non-small-cell Lung Cancer Patients: Ready for First-line?" Ann Transl Med 2019.
Atenció: Aquestes cites poden no estar 100% correctes.